SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001236031-20-000021
Filing Date
2020-04-20
Accepted
2020-04-20 16:58:47
Documents
1
Period of Report
2020-04-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4615
  Complete submission text file 0001236031-20-000021.txt   6071
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Issuer) CIK: 0000725363 (see all company filings)

IRS No.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 8229 BOONE BLVD STE 802 VIENNA VA 22182
Business Address
YOUNG PETER R (Reporting) CIK: 0001238029 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11889 | Film No.: 20803114